These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 890789)
1. [Choice of the most suitable oral steroid contraceptive]. Presl J Cesk Gynekol; 1977 Aug; 42(7):523-5. PubMed ID: 890789 [No Abstract] [Full Text] [Related]
2. [Directions for classification and indications of oral contraceptives (author's transl)]. d'Ernst JP; Lutz K; Stamm H Schweiz Rundsch Med Prax; 1977 Dec; 66(50):1620-7. PubMed ID: 594055 [TBL] [Abstract][Full Text] [Related]
3. Hormonal contraception: the current situation. Elstein M Practitioner; 1975 Oct; 215(1288):508-19. PubMed ID: 1202471 [No Abstract] [Full Text] [Related]
4. [New results in the field of hormonal contraceptives]. Lauritzen C Med Welt; 1975 Mar; 26(11):486-93. PubMed ID: 1121248 [No Abstract] [Full Text] [Related]
6. [The benefit of the classification of oral contraceptives. Studies of 525 women taking oral contraceptives (author's transl)]. Wenderlein JM MMW Munch Med Wochenschr; 1981 Jun; 123(23):957-61. PubMed ID: 6789156 [TBL] [Abstract][Full Text] [Related]
7. [Calculation of estrogenic and gestagenic activity of oral hormonal contraceptive agents including a tabular review]. Kless-Och M Schweiz Rundsch Med Prax; 1972 Nov; 61(46):1418-24. PubMed ID: 5084999 [No Abstract] [Full Text] [Related]
8. Effect of oral contraceptive use on the incidence of impaired glucose tolerance and diabetes mellitus. Harvengt C Diabete Metab; 1992; 18(2):71-7. PubMed ID: 1511755 [TBL] [Abstract][Full Text] [Related]
9. [Advances in hormonal contraception]. Villanueva Egan LA; Pichardo Cuevas M Ginecol Obstet Mex; 2007 Jan; 75(1):35-42. PubMed ID: 17542267 [TBL] [Abstract][Full Text] [Related]
14. Changes in alpha 1-antitrypsin (AAT) and alpha 2-macroglobulin serum concentrations during treatment with oral estro-progestogens. Paternoster D; Maggino T; Valente S; Pengo V; Ongaro G Quad Sclavo Diagn; 1982 Jun; 18(2):132-9. PubMed ID: 6188185 [No Abstract] [Full Text] [Related]
15. Re: "Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease". Thorogood M; Yudkin P Am J Epidemiol; 1991 Nov; 134(9):1009; author reply 1009-10. PubMed ID: 1951289 [No Abstract] [Full Text] [Related]
16. [Hormonal contraception - possibilities and problems]. Göretzlehner G Z Gesamte Inn Med; 1983 Nov; 38(22):251-3. PubMed ID: 6666182 [TBL] [Abstract][Full Text] [Related]
17. [First hormonal contraceptive of adolescent girl]. Pienkowski C; Cartault A; Menendez M; Ponsar C; Lorenzini F Arch Pediatr; 2008 Jun; 15(5):586-8. PubMed ID: 18582681 [No Abstract] [Full Text] [Related]
18. [Hormonal contraception]. Imparato E Rass Int Clin Ter; 1970 Jan; 50(2):86-96. PubMed ID: 5436775 [No Abstract] [Full Text] [Related]
19. [Oral contraceptives with lower hormonal dosis]. Nesheim BI Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1219. PubMed ID: 968845 [TBL] [Abstract][Full Text] [Related]
20. Oral contraceptives and breast cancer. Edgren RA Fertil Steril; 1992 Dec; 58(6):1271-2. PubMed ID: 1459288 [No Abstract] [Full Text] [Related] [Next] [New Search]